Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Solid Biosciences Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 78 | 2 | 67 | −9 |
| Shares | 69.3M | 23.7K | 64.2M | −5.06M (−7.3%) |
| Value | $83.3M | $29.0K | $39.5M | −$43.8M (−52.5%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Solid Biosciences Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| K2 Principal Fund, L.P. | 2,909,102 | $1.79M | 0.31% |
| Laurion Capital Management LP | 1,156,600 | $712.0K | 0.03% |
| Ergoteles LLC | 255,900 | $158.0K | 0.00% |
| Oasis Management Co Ltd. | 222,400 | $137.0K | 0.02% |
| RBF Capital, LLC | 156,900 | $97.0K | 0.01% |
| Highland Private Wealth Management | 89,340 | $55.0K | 0.01% |
| Qube Research & Technologies Ltd | 59,981 | $37.0K | 0.00% |
| Atria Wealth Solutions, Inc. | 54,250 | $33.0K | 0.00% |
| Prudential Financial Inc | 46,200 | $28.0K | 0.00% |
| Acadian Asset Management LLC | 32,260 | $20.0K | 0.00% |
| LMR Partners LLP | 28,357 | $17.0K | 0.00% |
| Group One Trading, L.P. | 13,755 | $8.00K | 0.00% |
| Balyasny Asset Management LLC | 11,598 | $7.00K | 0.00% |
| Capital Advisors, Ltd. LLC | 1,859 | $1.00K | 0.00% |
| Credit Suisse AG | 32 | $0 | 0.00% |
| Investors Research Corp | 600 | $0 | 0.00% |
Sold out (25)
Institutions that held Solid Biosciences Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Solid Biosciences Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 16,500 | $20.0K |
| Amalgamated Financial Corp. | 7,178 | $9.00K |